Carolina Guzmán-Brambila

Dr. Carolina Guzmán-Brambila

Tecnologico de Monterrey, Escuela de Medicina
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2015 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
CGCelia Gonzã¡Lez-Castillo
Celia Gonzã¡Lez-Castillo
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
Carolina Guzmán-BrambilaCarolina Guzmán-Brambila
Carolina Guzmán-Brambila
Merce PallasMerce Pallas
Merce Pallas
ARArgelia E. Rojas-Mayorquín
Argelia E. Rojas-Mayorquín
Pleiotrophin (PTN) is a secreted growth factor, and also a cytokine, associated with the extracellular matrix, which has recently starting to attract attention as a significant neuromodulator with multiple neuronal functions during development. PTN is expressed in several tissues, where its signals are generally related with cell proliferation, growth, and differentiation by acting through different receptors. In Central Nervous System (CNS), PTN exerts post-developmental neurotrophic and -protective effects, and additionally has been involved in neurodegenerative diseases and neural disorders. Studies in Drosophila shed light on some aspects of the different levels of regulatory control of PTN invertebrate homologs. Specifically in hippocampus, recent evidence from PTN Knock-out (KO) mice involves PTN functioning in learning and memory. In this paper, we summarize, discuss, and contrast the most recent advances and results that lead to proposing a PTN as a neuromodulatory molecule in the CNS, particularly in hippocampus.

16 July 2014 in Journal of Molecular Neuroscience
Verified
Journal Article
Closed access
PDF file
SBSergi Bayod
Sergi Bayod
Carolina Guzmán-BrambilaCarolina Guzmán-Brambila
Carolina Guzmán-Brambila
SSSandra Sanchez-Roige
Sandra Sanchez-Roige
JLJaume F. Lalanza
Jaume F. Lalanza
PKPerla Kaliman
Perla Kaliman
Merce PallasMerce Pallas
Merce Pallas

12 September 2012 in Clinical and Vaccine Immunology
Verified
Journal Article
Open access
PDF file
Carolina Guzmán-BrambilaCarolina Guzmán-Brambila
Carolina Guzmán-Brambila
ARArgelia E. Rojas-Mayorquín
Argelia E. Rojas-Mayorquín
BFBeatriz Flores-Samaniego
Beatriz Flores-Samaniego
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
Histophilus somniis an economically important pathogen of cattle and other ruminants and is considered one of the key components of the bovine respiratory disease (BRD) complex, the leading cause of economic loss in the livestock industry. BRD is a multifactorial syndrome, in which a triad of agents, including bacteria, viruses, and predisposing factors or “stressors,” combines to induce disease. Although vaccines againstH. somnihave been used for many decades, traditional bacterins have failed to demonstrate effective protection in vaccinated animals. Hence, the BRD complex continues to produce strong adverse effects on the health and well-being of stock and feeder cattle. The generation of recombinant proteins may facilitate the development of more effective vaccines againstH. somni, which could confer better protection against BRD. In the present study, primers were designed to amplify, clone, express, and purify two recombinant lipoproteins fromH. somni, p31 (Plp4) and p40 (LppB), which are structural proteins of the outer bacterial membrane. The results presented here demonstrate, to our knowledge for the first time, that when formulated, an experimental vaccine enriched with these two recombinant lipoproteins generates high antibody titers in rabbits and sheep and exerts a protective effect in mice against septicemia induced byH. somnibacterial challenge.

1 September 2016 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
CGCelia González-Castillo
Celia González-Castillo
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún
Carolina Guzmán-BrambilaCarolina Guzmán-Brambila
Carolina Guzmán-Brambila
AMAna Laura Márquez-Aguirre
Ana Laura Márquez-Aguirre
RRRita Raisman-Vozari
Rita Raisman-Vozari
ARArgelia E. Rojas-Mayorquín
Argelia E. Rojas-Mayorquín

1 December 2012 in Research in Veterinary Science
Verified
Journal Article
Closed access
Carolina Guzmán-BrambilaCarolina Guzmán-Brambila
Carolina Guzmán-Brambila
SQSaray Saray Quintero Quintero
Saray Saray Quintero Quintero
CGCelia González-Castillo
Celia González-Castillo
ÁVÁlvaro de Obeso-Fernández del Valle
Álvaro de Obeso-Fernández del Valle
BFBeatriz Flores-Samaniego
Beatriz Flores-Samaniego
Daniel Ortuño-SahagúnDaniel Ortuño-Sahagún
Daniel Ortuño-Sahagún

15 December 2020 in Brain Sciences
Verified
Journal Article
Open access
PDF file
Pedro Juárez RodríguezPedro Juárez Rodríguez
Pedro Juárez Rodríguez
Juliana Marisol Godínez-RubíJuliana Marisol Godínez-Rubí
Juliana Marisol Godínez-Rubí
Carolina Guzmán-BrambilaCarolina Guzmán-Brambila
Carolina Guzmán-Brambila
EPEdgar Padilla-Velarde
Edgar Padilla-Velarde
AOArturo Orozco-Barocio
Arturo Orozco-Barocio
ARArgelia E. Rojas-Mayorquín
Argelia E. Rojas-Mayorquín
Maternal ethanol consumption during pregnancy is one of the main causes of Neurodevelopmental disorders (NDD). Prenatal alcohol exposure (PAE) produces several adverse manifestations. Even low or moderate intake has been associated with long-lasting behavioral and cognitive impairment in offspring. In this study we examined the gene expression profile in the rat nucleus accumbens using microarrays, comparing animals exposed prenatally to ethanol and controls. Microarray gene expression showed an overall downward regulatory effect of PAE. Gene cluster analysis reveals that the gene groups most affected are related to transcription regulation, transcription factors and homeobox genes. We focus on the expression of the C-X-C motif chemokine ligand 16 (Cxcl16) which was differentially expressed. There is a significant reduction in the expression of this chemokine throughout the brain under PAE conditions, evidenced here by quantitative polymerase chain reaction qPCR and immunohistochemistry. Chemokines are involved in neuroprotection and implicated in alcohol-induced brain damage and neuroinflammation in the developing central nervous system (CNS), therefore, the significance of the overall decrease in Cxcl16 expression in the brain as a consequence of PAE may reflect a reduced ability in neuroprotection against subsequent conditions, such as excitotoxic damage, inflammatory processes or even hypoxic-ischemic insult.